This Biotech Is Experiencing A Coronavirus Surge

While it could be a year or more before a vaccine for the new coronavirus is ready for market, significant progress in the development of a vaccine appears to have already been made – and one biotech company, working with the National Institute of Allergy and Infectious Diseases to develop a treatment for the coronavirus, has seen its stock surge on this progress. CLICK HERE.